Osteopore shares digitalisation initiatives to increase efficiency. — Read more
In a major new development, bone healing company Osteopore (ASX:OSX) has been granted a patent in China for its ‘smart’ 3D biometric scaffolds. — Read more
Medical technology company Singular Health has partnered with innovative Australian scientific research agency CSIRO, on a project that is looking to develop an artificial intelligence-based tool to automatically design replacement “cranial implants” for 3D printing. The company has also entered into a collaboration with ASX-listed Osteopore to validate results of the project. — Read more
At Osteopore, one of our guiding principles is the value of collaboration. We believe that it is foundational to success and are always seeking to learn from and add value to our partners. — Read more
Osteopore teams up with Brisbane plastic and reconstructive surgeon for bone scaffold trials
Aug 2021
Regenerative implant innovators Osteopore and plastic and reconstructive surgeon Dr Michael Wagels have teamed up to conduct two ground-breaking human clinical trials. — Read more
After revolutionising reconstructive surgeries with regenerative implants that promote natural bone healing and tissue repair, Osteopore International is globalising its devices for broader use in dental, orthopaedic and spinal surgeries. — Read more
Medtech company Osteopore (ASX: OSX) will soon have it’s 3D-printed bone regeneration products in the view of major international medical markets through a new collaboration with one of the world’s largest medical companies. — Read more